Development of Novel Combination Therapies

被引:218
作者
Woodcock, Janet [1 ]
Griffin, Joseph P. [2 ]
Behrman, Rachel E. [2 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[2] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
D O I
10.1056/NEJMp1101548
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:985 / 987
页数:3
相关论文
共 4 条
[1]  
AD L, 2010, SCIENCE, V328, P137
[2]   I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy [J].
Barker, A. D. ;
Sigman, C. C. ;
Kelloff, G. J. ;
Hylton, N. M. ;
Berry, D. A. ;
Esserman, L. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (01) :97-100
[3]  
*FOOD DRUG ADM, 2010, GUID IND CH IN PRESS
[4]  
*FOOD DRUG ADM, 2010, GUID IND CO IN PRESS